{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:45:30Z","timestamp":1764103530506},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"RefleXion"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-024-02502-w","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T19:01:48Z","timestamp":1726686108000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility of Biology-guided Radiotherapy (BgRT) Targeting Fluorodeoxyglucose (FDG) avid liver metastases"],"prefix":"10.1186","volume":"19","author":[{"given":"Brittney","family":"Chau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Abuali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shervin M.","family":"Shirvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine A.","family":"Al Feghali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanta","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arya","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"2502_CR1","doi-asserted-by":"crossref","unstructured":"Sm S, Cj H et al. T M,. Biology-guided radiotherapy: redefining the role of radiotherapy in metastatic cancer. The British journal of radiology 2021;94(1117).","DOI":"10.1259\/bjr.20200873"},{"key":"2502_CR2","unstructured":"Mazin S. Biology-guided Radiation Therapy \u2014 A look at the Not-So-Distant future of Cancer Treatment. In 21. Radiology Today Magazine:8."},{"issue":"9","key":"2502_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3109\/0284186X.2015.1076992","volume":"54","author":"G C","year":"2015","unstructured":"C G, Jc JOMHKT, Lp L. Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncol (Stockholm Sweden). 2015;54(9):1245\u201350.","journal-title":"Acta Oncol (Stockholm Sweden)"},{"issue":"2","key":"2502_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.21037\/jgo.2018.11.03","volume":"10","author":"EJ Anstadt","year":"2019","unstructured":"Anstadt EJ, Shumway R, Colasanto J, Grew D. Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases. J Gastrointest Oncol. 2019;10(2):330\u2013330.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"2502_CR5","first-page":"190","volume":"5","author":"M Scorsetti","year":"2014","unstructured":"Scorsetti M, Clerici E, Comito T. Stereotactic body radiation therapy for liver metastases. J Gastrointest Oncol. 2014;5(3):190\u2013190.","journal-title":"J Gastrointest Oncol"},{"issue":"10185","key":"2502_CR6","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet (London England). 2019;393(10185):2051\u20138.","journal-title":"Lancet (London England)"},{"issue":"12","key":"2502_CR7","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez DR, Blumenschein GR, Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672\u201382.","journal-title":"Lancet Oncol"},{"key":"2502_CR8","doi-asserted-by":"crossref","unstructured":"Iyengar P, Wardak Z, Gerber DE et al. Consolidative Radiotherapy for Limited Metastatic Non-small-cell Lung Cancer: a phase 2 Randomized Clinical Trial. JAMA Oncol 2018;4(1).","DOI":"10.1001\/jamaoncol.2017.3501"},{"key":"2502_CR9","doi-asserted-by":"crossref","unstructured":"Onishi H, Shirato H, Nagata Y et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncology: Official Publication Int Association Study Lung Cancer 2007;2(7 Suppl 3).","DOI":"10.1097\/JTO.0b013e318074de34"},{"key":"2502_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2021.08.005","volume":"163","author":"A Farooqi","year":"2021","unstructured":"Farooqi A, Ludmir EB, Mitchell KG, et al. Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC. Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol. 2021;163:114\u20138.","journal-title":"Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"5","key":"2502_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2217\/iim.10.49","volume":"2","author":"S Tong","year":"2010","unstructured":"Tong S, Alessio AM, Kinahan PE. Image reconstruction for PET\/CT scanners: past achievements and future challenges. Imaging Med. 2010;2(5):529\u201345.","journal-title":"Imaging Med"},{"issue":"12","key":"2502_CR12","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1088\/0031-9155\/54\/12\/007","volume":"54","author":"MS Tohme","year":"2009","unstructured":"Tohme MS, Qi J. Iterative image reconstruction for positron emission tomography based on a detector response function estimated from point source measurements. Phys Med Biol. 2009;54(12):3709\u201325.","journal-title":"Phys Med Biol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-024-02502-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-024-02502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T19:03:33Z","timestamp":1726686213000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-024-02502-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1186\/s13014-024-02502-w","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"14 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"124"}}